rs121913246
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Emergence of the preexisting MET Y1230C likely confers resistance to crizotinib in this case of METex14-positive NSCLC.
|
27666659 |
2017 |
rs121913247
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Acquired <i>MET</i> Y1248H and D1246N Mutations Mediate Resistance to MET Inhibitors in Non-Small Cell Lung Cancer.
|
28396313 |
2017 |
rs121913671
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Acquired <i>MET</i> Y1248H and D1246N Mutations Mediate Resistance to MET Inhibitors in Non-Small Cell Lung Cancer.
|
28396313 |
2017 |
rs41281081
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Our findings have shown that the SNPs rs41281081 and rs76322625 in MET 3'UTR, through disruption of the regulatory role of miR-335 and miR-1026 in MET expression, may act as promoting factors in the pathogenesis of NSCLC.
|
26402720 |
2015 |
rs76322625
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Our findings have shown that the SNPs rs41281081 and rs76322625 in MET 3'UTR, through disruption of the regulatory role of miR-335 and miR-1026 in MET expression, may act as promoting factors in the pathogenesis of NSCLC.
|
26402720 |
2015 |
rs33917957
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Specific expression of phospho-Met (p-Met) [Y1003] and [Y1230/1234/1235] was seen by immunohistochemistry. p-Met expression was preferentially observed at the NSCLC tumor invasive fronts. c-Met alterations were identified within the semaphorin domain (E168D, L299F, S323G, and N375S) and the juxtamembrane domain (R988C, R988C + T1010I, S1058P, and alternative splice product skipping entire juxtamembrane domain) of a NSCLC cell line and adenocarcinoma tissues.
|
15735036 |
2005 |
rs55985569
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Specific expression of phospho-Met (p-Met) [Y1003] and [Y1230/1234/1235] was seen by immunohistochemistry. p-Met expression was preferentially observed at the NSCLC tumor invasive fronts. c-Met alterations were identified within the semaphorin domain (E168D, L299F, S323G, and N375S) and the juxtamembrane domain (R988C, R988C + T1010I, S1058P, and alternative splice product skipping entire juxtamembrane domain) of a NSCLC cell line and adenocarcinoma tissues.
|
15735036 |
2005 |